Physician profile
Christopher Jordan
NPI 1528009693
$8,429.06
in general payments reported to CMS, 2019-2025
11 companies · $93.10 in 2025
The $93.10 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,561 · 2020: $501 · 2021: $1,200 · 2022: $1,721 · 2023: $1,189 · 2024: $164 · 2025: $93.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818 · Travel and Lodging: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.09 |
| Travel and Lodging | $628.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,181.57 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,589.15 | 2022-2024 | Gel-One Cross-Linked Hyaluronate, Visco-3 Sodium Hyaluronate |
| Pylant Medical | $1,319.02 | 2019-2021 | |
| Stryker Corporation | $1,249.90 | 2022-2025 | Salvation, Inspace, Na |
| Trice Medical, INC. | $628.22 | 2019-2020 | |
| Janssen Biotech, INC. | $130.35 | 2023 | Simponi Aria |
| Pavmed INC. | $121.81 | 2022 | |
| Pfizer INC. | $99.62 | 2020 | |
| Depuy Synthes Sales INC. | $50.80 | 2024-2025 | Truespan Orthocord, Healix Knotless Peek, Dynacord |
| Array Biopharma INC | $33.41 | 2020 | |
| Innovation Technologies INC | $25.21 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.